KRYS - Krystal Biotech, Inc.
260.33
-4.670 -1.794%
Share volume: 276,507
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$265.00
-4.67
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-06-2024 | 08-05-2024 | 11-04-2024 | 02-19-2025 | 05-06-2025 | 08-04-2025 | 11-03-2025 | 02-17-2026 | |
| Total revenue | 45.250 M | 70.284 M | 83.841 M | 91.140 M | 88.183 M | 96.042 M | 97.800 M | 107.105 M | |
| Cost of revenue | 2.419 M | 6.009 M | 6.684 M | 4.949 M | 5.028 M | 7.165 M | 4.263 M | 6.593 M | |
| Gross profit | 42.831 M | 64.275 M | 77.157 M | 86.191 M | 83.155 M | 88.877 M | 93.537 M | 100.512 M | |
| 50.07% | 20.04% | 11.71% | -3.52% | 6.88% | 5.24% | 7.46% | |||
| Operating expenses | 37.015 M | 43.209 M | 42.224 M | 44.811 M | 46.978 M | 49.570 M | 52.163 M | 56.075 M | |
| Selling general and admin | 26.058 M | 27.626 M | 28.713 M | 31.289 M | 32.723 M | 35.160 M | 37.578 M | 41.280 M | |
| Research and development | 10.957 M | 15.583 M | 13.511 M | 13.522 M | 14.255 M | 14.410 M | 14.585 M | 14.795 M | |
| Total expenses | 49.515 M | 55.709 M | 54.724 M | 44.811 M | 46.978 M | 49.570 M | 52.163 M | 56.075 M | |
| 12.51% | -1.77% | -18.11% | 4.84% | 5.52% | 5.23% | 7.50% | |||
| Operating income | -6.684 M | 8.566 M | 22.433 M | 41.380 M | 36.177 M | 39.307 M | 41.374 M | 44.437 M | |
| Ebit | 932.000 K | 16.045 M | 22.433 M | 26.285 M | 36.177 M | 39.307 M | 41.374 M | 44.437 M | |
| Pretax income | 932.000 K | 16.045 M | 29.769 M | 48.610 M | 43.597 M | 46.775 M | 47.967 M | 51.132 M | |
| 1,621.57% | 85.53% | 63.29% | -10.31% | 7.29% | 2.55% | 6.60% | |||
| Income tax | 0.000 | 477.000 K | 2.589 M | 0.000 | 7.864 M | 8.442 M | -31.398 M | -268.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 932.000 K | 15.568 M | 27.180 M | 45.479 M | 35.733 M | 38.333 M | 79.365 M | 51.400 M | |
| 1,570.39% | 74.59% | 67.33% | -21.43% | 7.28% | 107.04% | -35.24% |